Shares of Synergy Pharmaceuticals (SGYP) rose 10% to $4.00 in Friday trading. On Thursday, Cantor Fitzgerald started coverage of the New York firm's shares with an overweight rating and an $11 price target.

Shares of Bluebird Bio (BLUE)  gained 6.3% to $84.15 on the heels of an upgrade to buy from hold by analysts at Maxim Group. In a note on Friday, the analysts said they believe that the event that could "break BLUE shares out of the current valuation range is bb2121 CAR-T data in multiple myeloma" that will be presented at the American Society of Clinical Oncology's annual meeting. The conference takes place June 2 - 6 in Chicago.

Among the other biotech movers was DBV Technologies (DBVT) . The Bagneux, France-based firm's American depository shares were up 2.2% to $34.90.

Jim Cramer and the AAP team explain why they have downgraded HP Enterprise's (HPE) stock to Two from One. Find out what they are telling their investment club members. Get a free trial subscription to Action Alerts PLUS.

Meanwhile, over on Real Money, Cramer discusses why Lululemon's (LULU) stock made him waver. Get his insights or analysis with a free trial subscription to Real Money.

Click here for the latest business headlines.

Editor's Pick: Originally published June 2.

More from Health

How to Retire Rich - 25 of the Best Secrets We Learned in 2018

How to Retire Rich - 25 of the Best Secrets We Learned in 2018

How to Invest in Cannabis - In Its Many Forms

How to Invest in Cannabis - In Its Many Forms

Is CBD Oil Legal? State-By-State and Future Legality

Is CBD Oil Legal? State-By-State and Future Legality

Unilever Taps In-House Executive as CEO

Unilever Taps In-House Executive as CEO

Open Enrollment Means Costly Changes for Some Medicare Advantage Beneficiaries

Open Enrollment Means Costly Changes for Some Medicare Advantage Beneficiaries